|
|||||
|
|
Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia |
|
| Authors: | Himalee S. Sabnis Caroline Keenum Rebecca W. Lewis Briana Patterson John Bergsagel Karen E. Effinger Emily Silverman Ann C. Mertens Sharon M. Castellino |
| Affiliation: | 1. Department of Pediatrics, Division of Haematology/Oncology/Bone Marrow Transplantation, Emory University, Atlanta, GA, USA;2. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA;3. Department of Pediatrics, Division of Haematology/Oncology/Bone Marrow Transplantation, Emory University, Atlanta, GA, USA Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA Department of Pediatrics, Division of Endocrinology, Emory University, Atlanta, GA, USA;4. Department of Pediatrics, Division of Haematology/Oncology/Bone Marrow Transplantation, Emory University, Atlanta, GA, USA Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA |
| Abstract: | |
| Keywords: | protein kinase inhibitors chronic myeloid leukaemia Philadelphia chromosome-positive acute lymphoblastic leukaemia body height growth |